Inhalation Sciences to present at Redeye Life Science Day November 11

Report this content

(Stockholm, 4 November, 2021) Inhalation Sciences (ISAB) CEO Manoush Masarrat will present the latest developments for the company at Redeye Life Science Day on November 11. ISAB provide high-precision equipment and research services for aerosol and inhalation studies that can de-risk drug development projects.

Redeye Life Science Day is a digital event where up to 50 companies will present their business and technologies, and take questions from  analysts and experts.

The presentation is live broadcasted and can be followed at:

The presentation will also be available at and on ISAB’s website:

For more information on Inhalation Sciences, please contact:

Manoush Masarrat, CEO


Mobile: +46 (0)73 628 9153

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.